Please use this link to access this publication. Abstract The use of cannabis is highly prevalent worldwide, with known short and long-term adverse effects. However, the relationship between cannabis use…
Condition: Mental Disorders
Rates and correlates of cannabis-associated psychotic symptoms in over 230,000 people who use cannabis
Abstract Cannabis, a widely used psychoactive substance, can trigger acute cannabis-associated psychotic symptoms (CAPS) in people who use cannabis (PWUC). To assess rates and correlates of CAPS requiring emergency medical…
Risk-thresholds for the association between frequency of cannabis use and the development of psychosis: a systematic review and meta-analysis
Abstract BackgroundEpidemiological studies show a dose–response association between cannabis use and the risk of psychosis. This review aimed to determine whether there are identifiable risk-thresholds between the frequency of cannabis…
Cannabis induced psychosis: A systematic review on the role of genetic polymorphisms
Abstract Objective Cannabis sativa is a recreational drug commonly consumed in Europe and is getting popularity for both recreational and therapeutic use. In some individuals, the use of cannabis leads to psychotic…
Cannabis and Psychosis: Recent Epidemiological Findings Continuing the “Causality Debate”
Abstract Nonmedical (“recreational”) cannabis use and cannabis laws have changed over the past two decades in the United States (1) and the rest of the world (2). Increasing use, especially…
Functional interactions between cannabinoids, omega-3 fatty acids, and peroxisome proliferator-activated receptors: Implications for mental health pharmacotherapies
Please use this link to access this publication. Abstract Cannabis contains a plethora of phytochemical constituents with diverse neurobiological effects. Cannabidiol (CBD) is the main non-psychotropic component found in cannabis…
Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions
Abstract Combination tetrahydrocannabinol (THC)/cannabidiol (CBD) medicines or CBD-only medicines are prospective treatments for chronic pain, stress, anxiety, depression, and insomnia. THC and CBD increase signaling from cannabinoid receptors, which reduces…
A scoping review of the use of cannabidiol in psychiatric disorders
Please use this link to access this publication. Abstract Cannabidiol (CBD) has become a fast-growing avenue for research in psychiatry, and clinicians are challenged with understanding the implications of CBD for treating…
Different Effects of Nabilone and Cannabidiol on Binocular Depth Inversion in Man
Please use this link to access this publication. Abstract The physiological and pathophysiological roles of the central nervous endogenous cannabinoid system are not completely understood, but still represent a challenge in basic…
Mental health adverse events with cannabis use diagnosed in the Emergency Department: what are we finding now and are our findings accurate?
Abstract We have previously reviewed the types and numbers of cannabis-associated adverse events that have mental health presentations that are encountered in the Emergency Department. A particular challenge in examining…